Phreesia Named to Capterra 2025 Shortlist for Patient Engagement and Medical Scheduling
PorAinvest
martes, 12 de agosto de 2025, 4:07 pm ET1 min de lectura
PHR--
The Capterra Shortlist is an independent assessment that evaluates user reviews and online search activity to identify market leaders in various software categories. Phreesia's inclusion in this prestigious list is a testament to its positive reputation among healthcare providers, as evidenced by its overall rating of 4.3 out of 5 on Capterra.
Phreesia's CEO, Chaim Indig, expressed his pride in the achievement, stating, "Being named to two of the 2025 Capterra Shortlists is an honor that reflects the positive reviews and feedback we receive from our healthcare provider clients. Our digital solutions help engage and empower patients to take a more active role in their care, and this award is a welcome recognition of those efforts."
Phreesia has been instrumental in managing approximately 170 million patient visits in 2024, representing one in seven visits across the U.S. The company's digital solutions, which include patient-driven intake, outreach, education, and more, have significantly enhanced the patient experience, driven efficiency, and improved healthcare outcomes.
For more information about Phreesia, visit [Phreesia's official website](https://www.phreesia.com).
References:
[1] https://www.businesswire.com/news/home/20250812215331/en/Phreesia-Named-to-the-2025-Capterra-Shortlist-for-Patient-Engagement-and-Medical-Scheduling
[2] https://www.stocktitan.net/news/PHR/phreesia-named-to-the-2025-capterra-shortlist-for-patient-engagement-k02frsbgoa55.html
Phreesia has been named to the 2025 Capterra Shortlist in the Patient Engagement and Medical Scheduling categories. The Capterra Shortlist evaluates user reviews and search activity to identify market leaders. Phreesia's digital solutions engage and empower patients to take an active role in their care, and it has an overall rating of 4.3 out of 5 on Capterra.
Phreesia, a leading provider of patient intake, outreach, and activation solutions, has been named to the 2025 Capterra Shortlist in the Patient Engagement and Medical Scheduling categories. This recognition underscores the company's commitment to enhancing patient experiences and empowering patients to take a more active role in their healthcare.The Capterra Shortlist is an independent assessment that evaluates user reviews and online search activity to identify market leaders in various software categories. Phreesia's inclusion in this prestigious list is a testament to its positive reputation among healthcare providers, as evidenced by its overall rating of 4.3 out of 5 on Capterra.
Phreesia's CEO, Chaim Indig, expressed his pride in the achievement, stating, "Being named to two of the 2025 Capterra Shortlists is an honor that reflects the positive reviews and feedback we receive from our healthcare provider clients. Our digital solutions help engage and empower patients to take a more active role in their care, and this award is a welcome recognition of those efforts."
Phreesia has been instrumental in managing approximately 170 million patient visits in 2024, representing one in seven visits across the U.S. The company's digital solutions, which include patient-driven intake, outreach, education, and more, have significantly enhanced the patient experience, driven efficiency, and improved healthcare outcomes.
For more information about Phreesia, visit [Phreesia's official website](https://www.phreesia.com).
References:
[1] https://www.businesswire.com/news/home/20250812215331/en/Phreesia-Named-to-the-2025-Capterra-Shortlist-for-Patient-Engagement-and-Medical-Scheduling
[2] https://www.stocktitan.net/news/PHR/phreesia-named-to-the-2025-capterra-shortlist-for-patient-engagement-k02frsbgoa55.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios